As of 2025-06-03, the Fair Value of Metacrine, Inc. (MTCR) is -4.49 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.49 USD, the upside of Metacrine, Inc. is -1,006.34%.
With the market price of 0.49 USD and our fair value calculation, Metacrine, Inc. (MTCR) is not a good investment. Investing in MTCR stocks now will result in a potential loss of 1,006.34%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 5Y Avg | |
| Net income | -12.26 | -25.82 | -28.93 | -37.30 | -62.21 | -33.30 |
| YoY growth | -17.88% | -110.60% | -12.04% | -28.93% | -66.77% | -47.25% |
| Market Cap (mil) | 21.07 |
| P/E | |
| Forward P/E |
| EPS | -0.90 |
| Avg earnings growth rate | -47.25% |
| TTM earnings | -38.19 |